Predictors of occult bacteremia in young febrile children in the era of heptavalent pneumococcal conjugated vaccine

European Journal of Emergency Medicine

Volumn 16, Issue 4, 2009, Pages 199-205

  Mintegi, Santiago ^a   Benito, Javier ^a   Sanchez, Jesus ^a   Azkunaga, Beatriz ^a   Iturralde, Itziar ^a   Garcia, Silvia ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

Fever; Infant; Occult bacteremia

Indexed keywords

PNEUMOCOCCUS VACCINE;

ARTICLE; BACTEREMIA; BLOOD CULTURE; CHILD; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; FEVER; HUMAN; INFANT; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

BACTEREMIA; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; LEUKOCYTE COUNT; LEUKOCYTOSIS; NEUTROPHILS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; VACCINES, CONJUGATE;

EID: 68949109868     PISSN: 09699546     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEJ.0b013e32831cefc9     Document Type: Article

References (26)

1. Slater M, Krug SE. Evaluation of the infant with fever source: an evidence based approach. Emerg Med Clin North Am 1999; 17:97-126.
2. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post-Haemophilus influenzae type b era. Arch Pediatr Adolesc Med 1998; 152:624-628.
3. Mintegi S, Benito J, Garc?́a S, Corrales A, Bartolome MJ, Trebolazabala N. Patient demand and management in a hospital pediatric emergency setting. An Pediatr (Barc) 2004; 61:156-161.
4. Mintegi S, González M, Pérez A, Pijoán JI, Capape S, Benito J. Lactante de 3-24 meses con fiebre sin foco en urgencias: caracter?́sticas, tratamiento y evolución posterior. An Pediatr 2005; 62:522-528.
5. Benito-Fernandez J, Mintegi-Raso S, Gonzalez-Balenciaga M, Capape-Zache S, Sanchez-Etxaniz J, Garcia-Gonzalez S. Pneumococcal bacteremia among infants with fever without source before and after introduction of pnemococcal conjugate vaccine in Basque Country (Spain). Pediatr Infect Dis J 2007; 19:187-195.
6. Stoll ML, Rubin LG. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine. A study from a Children's hospital emergency department and urgent care center. Arch Pediatr Adolesc Med 2004; 158:671-675.
7. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen J, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children: northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19:187-195.
8. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348:1737-1746.
9. Herz AM, Greenhow TL, Alcantara J, Hansen J, Baxter RP, Black SB, Shinefield HR. Changing epidemiology of outpatient bacteremia in 3- to-36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine. Pediatr Infect DisJ 2006; 25:293-300.
10. Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clin Infect Dis 2006; 42:907-914.
11. Mintegi S, Benito J, González M, Astobiza E, Sánchez J, Santiago M. Impact of the pneumococcal conjugate vaccine in the management of highly febrile children aged 6-24 months in an emergency department. Pediatr Emerg Care 2006; 22:566-569.
12. Kuppermann N. Occult bacteremia in young febrile children. Pediatr Clin North Am 1999; 46:1073-1109.
13. Kuppermann N, Fleisher GR, Jaffe DM. Predictors of occult pneumococcal bacteremia in young febrile children. Ann Emerg Med 1998; 31:679-687.
14. Carstairs KL, Tanen DA, Johnson AS, Kailes SB, Riffenburgh RH. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine. Ann Emerg Med 2007; 49:772-777.
15. Antonyrajah B, Mukundan D. Fever without apparent source on clinical examination. Curr Opin Pediatr 2008; 20:96-102.
16. http://seup.org/seup/html/gtrabajo/cod-diagnostica.htm (last visited 08-July-21).
17. Rodriguez Serna A, Astibiza Beobide E, González Balenciaga M, Azkunaga Santibañez B, Benito Fernandez J, Mintegi Raso S. Cambios de los hábitos poblacionales en el tratamiento de la fiebre en la infancia. An Pediatr (Barc) 2006; 64:496-502.
18. LeeGM, Fleisher GR, Harper MB. Management of febrile children in the age of conjugate pneumococcal vaccine: a cost-effectiveness analysis. Pediatrics 2001; 108:835-844.
19. Lieu T, Schwartz S, Jaffe D, Fleisher G. Strategies for diagnosis and treatment of children at risk for occult bacteremia: clinical effectiveness and cost-effectiveness. J Pediatr 1991; 118:21-29.
20. Downs S, McNutt R, Margolis P. Management of infants at risk for occult bacteremia: a decision analysis. J Pediatr 1991; 118:11-20.
21. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics 2001; 108:1275-1279.
22. Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med 2002; 156:905-909.
23. Jones AE, Flechtl JF, Brown MD, Ballew JJ, Kline JA. Procalcitonin test in the diagnosis of bacteremia: a meta-analysis. Ann Emerg Med 2006; 50:34-41.
24. Andreola B, Bressan S, Callegaro S, Liverani A, Plebani M, Da Dalt L, et al. Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J 2007; 26:672-677.
25. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784-1792.
26. Belfer RA, Gittelman MA, Muniz AE. Management of febrile infants and children by pediatric emergency medicine and emergency medicine: comparison with practice guidelines. Pediatr Emerg Care 2001; 17:83-87.